Taniborbactam is a novel, broad-spectrum beta-lactamase inhibitor designed to combat multidrug-resistant Gram-negative bacterial infections by restoring the efficacy of co-administered beta-lactam antibiotics.… Read more
Taniborbactam is a novel, broad-spectrum beta-lactamase inhibitor designed to combat multidrug-resistant Gram-negative bacterial infections by restoring the efficacy of co-administered beta-lactam antibiotics. By covalently binding to beta-lactamases, this compound prevents the hydrolysis and inactivation of essential antimicrobial agents. This category offers high-quality reference standards for Taniborbactam API and its associated compounds, including stable isotope-labelled versions such as Taniborbactam-d4. These materials are critical for laboratories performing rigorous impurity profiling, method development, and validation to ensure the quality and consistency of pharmaceutical formulations. Researchers and analytical chemists utilize these specific reference materials to monitor synthesis by-products, support pharmacopeial testing, and facilitate the precise identification of related substances during the lifecycle of drug development and quality control.